Rivarax 10 mg

Rivarax 10 mg is a medicine authorised by Swissmedic under authorisation number 69032. The authorisation holder is Drossapharm AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 January 2024 and the authorisation is limited until 28 January 2029. ATC code B01AF01 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 69032
  • ATC B01AF01
  • Synthetic medicines
Authorisation data
Authorisation number69032
NameRivarax 10 mg
Full nameRivarax 10 mg, Filmtabletten
Authorisation holderDrossapharm AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeB01AF01
First authorisation29 January 2024
Authorisation validity28 January 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Rivarax 10 mg, FilmtablettenB29 January 2024
2Rivarax 15 mg, FilmtablettenB29 January 2024
3Rivarax 20 mg, FilmtablettenB29 January 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110Tablette(n)B01AF0106.03.0.B
230Tablette(n)B01AF0106.03.0.B
3100Tablette(n)B01AF0106.03.0.B
410Tablette(n)B01AF0106.03.0.B
530Tablette(n)B01AF0106.03.0.B
6100Tablette(n)B01AF0106.03.0.B
710Tablette(n)B01AF0106.03.0.B
830Tablette(n)B01AF0106.03.0.B
9100Tablette(n)B01AF0106.03.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Rivarax 10 mg authorised in Switzerland?

Yes. Rivarax 10 mg is authorised by Swissmedic under authorisation number 69032, data as of 01 September 2026. The authorisation is limited until 28 January 2029.

Which dispensing category does Rivarax 10 mg have?

Rivarax 10 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Rivarax 10 mg?

The authorisation holder is Drossapharm AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com